Roudijk Rob W, Bosman Laurens P, van der Heijden Jeroen F, de Bakker Jacques M T, Hauer Richard N W, van Tintelen J Peter, Asselbergs Folkert W, Te Riele Anneline S J M, Loh Peter
Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, Utrecht University, 3508 GA Utrecht, The Netherlands.
Netherlands Heart Institute, 3511 EP Utrecht, The Netherlands.
J Clin Med. 2020 Feb 17;9(2):545. doi: 10.3390/jcm9020545.
Fragmented QRS complexes (fQRS) are common in patients with arrhythmogenic cardiomyopathy (ACM). A new method of fQRS quantification may aid early disease detection in pathogenic variant carriers and assessment of prognosis in patients with early stage ACM. Patients with definite ACM ( = 221, 66%), carriers of a pathogenic ACM-associated variant without a definite ACM diagnosis ( = 57, 17%) and control subjects ( = 58, 17%) were included. Quantitative fQRS (Q-fQRS) was defined as the total amount of deflections in the QRS complex in all 12 electrocardiography (ECG) leads. Q-fQRS was scored by a single observer and reproducibility was determined by three independent observers. Q-fQRS count was feasible with acceptable intra- and inter-observer agreement. Q-fQRS count is significantly higher in patients with definite ACM (54 ± 15) and pathogenic variant carriers (55 ± 10) compared to controls (35 ± 5) ( < 0.001). In patients with ACM, Q-fQRS was not associated with sustained ventricular arrhythmia ( = 0.701) at baseline or during follow-up ( = 0.335). Both definite ACM patients and pathogenic variant carriers not fulfilling ACM diagnosis have a higher Q-fQRS than controls. This may indicate that increased Q-fQRS is an early sign of disease penetrance. In concealed and early stages of ACM the role of Q-fQRS for risk stratification is limited.
碎裂QRS波群(fQRS)在致心律失常性心肌病(ACM)患者中很常见。一种新的fQRS量化方法可能有助于对致病基因变异携带者进行疾病早期检测,并评估早期ACM患者的预后。纳入了确诊为ACM的患者(n = 221,66%)、携带与ACM相关的致病基因变异但未确诊为ACM的携带者(n = 57,17%)以及对照受试者(n = 58,17%)。定量fQRS(Q-fQRS)定义为所有12导联心电图(ECG)中QRS波群的总偏转量。Q-fQRS由一名观察者评分,其可重复性由三名独立观察者确定。Q-fQRS计数可行,观察者内和观察者间一致性可接受。与对照组(35±5)相比,确诊为ACM的患者(54±15)和致病基因变异携带者(55±10)的Q-fQRS计数显著更高(P<0.001)。在ACM患者中,基线时或随访期间,Q-fQRS与持续性室性心律失常无关(P = 0.701)(P = 0.335)。确诊为ACM的患者和未达到ACM诊断标准的致病基因变异携带者的Q-fQRS均高于对照组。这可能表明Q-fQRS增加是疾病外显的早期迹象。在ACM的隐匿期和早期,Q-fQRS在风险分层中的作用有限。